1.      Aldossary AM, Tawfik EA, Alomary MN, et al. Recent advances in mitochondrial diseases: From molecular insights to therapeutic perspectives. Saudi Pharm J. 2022;30(8):1065-1078. doi:10.1016/j.jsps.2022.05.011

2.      Atkuri KR, Cowan TM, Kwan T, et al. Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. Proc Natl Acad Sci U S A. 2009;106(10):3941-3945. doi:10.1073/pnas.0813409106

3.      Ball M, Van Bergen NJ, Compton AG, Thorburn DR, Rahman S, Christodoulou J. Therapies for Mitochondrial Disease: Past, Present, and Future. J Inherit Metab Dis. 2025;48(4):e70065. doi:10.1002/jimd.70065

4.      Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8:333. doi:10.1038/s41392-023-01547-9

5.      Chi CS. Diagnostic Approach in Infants and Children with Mitochondrial Diseases. Pediatr Neonatol. 2015;56(1):7-18. doi:10.1016/j.pedneo.2014.03.009

6.      Chinnery PF. Primary Mitochondrial Disorders Overview.

7.      Conti F, Di Martino S, Drago F, et al. Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? Int J Mol Sci. 2023;24(23):16746. doi:10.3390/ijms242316746

8.      Davison J, Lemonde H, Rahman S. Inherited mitochondrial disease. Paediatr Child Health. 2019;29(3):116-122. doi:10.1016/j.paed.2019.01.009

9.      Distelmaier F, Haack TB, Wortmann SB, Mayr JA, Prokisch H. Treatable mitochondrial diseases: cofactor metabolism and beyond. Brain. 2017;140(2):e11. doi:10.1093/brain/aww303

10.  Frazier AE, Thorburn DR, Compton AG. Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology. J Biol Chem. 2019;294(14):5386-5395. doi:10.1074/jbc.R117.809194

11.  Gorman GS, Chinnery PF, DiMauro S, et al. Mitochondrial diseases. Nat Rev Dis Primer. 2016;2(1):16080. doi:10.1038/nrdp.2016.80

12.  Heath O, Feichtinger RG, Achleitner MT, et al. Mitochondrial disorder diagnosis and management– what the pediatric neurologist wants to know. Eur J Paediatr Neurol. 2025;54:75-88. doi:10.1016/j.ejpn.2024.10.009

13.  Hirano M, Emmanuele V, Quinzii CM. Emerging therapies for mitochondrial diseases. Garone C, Minczuk M, eds. Essays Biochem. 2018;62(3):467-481. doi:10.1042/EBC20170114

14.  Marcdante KJ, Kliegman RM, Nelson WE, eds. Nelson Essentials of Pediatrics. Eighth edition. Elsevier; 2019.

15.  Muraresku CC, McCormick EM, Falk MJ. Mitochondrial Disease: Advances in Clinical Diagnosis, Management, Therapeutic Development, and Preventative Strategies. Curr Genet Med Rep. 2018;6(2):62-72. doi:10.1007/s40142-018-0138-9

16.  Niyazov DM, Kahler SG, Frye RE. Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment. Mol Syndromol. 2016;7(3):122-137. doi:10.1159/000446586

17.  Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17(9):689-701. doi:10.1038/gim.2014.177

18.  Parikh S, Karaa A, Goldstein A, et al. Diagnosis of ‘possible’ mitochondrial disease: an existential crisis. J Med Genet. 2019;56(3):123-130. doi:10.1136/jmedgenet-2018-105800Parikh S, Goldstein A, Karaa A, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2017;19(12):1380-1397. doi:10.1038/gim.2017.107

19.  Rahman J, Rahman S. Mitochondrial medicine in the omics era. The Lancet. 2018;391(10139):2560-2574. doi:10.1016/S0140-6736(18)30727-X

20.  Rahman S. Mitochondrial disease in children. J Intern Med. 2020;287(6):609-633. doi:10.1111/joim.13054

21.  Schlieben LD, Prokisch H. The Dimensions of Primary Mitochondrial Disorders. Front Cell Dev Biol. 2020;8:600079. doi:10.3389/fcell.2020.600079

22.  Sofou K, Dahlin M, Hallböök T, Lindefeldt M, Viggedal G, Darin N. Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes. J Inherit Metab Dis. 2017;40(2):237-245. doi:10.1007/s10545-016-0011-5

23.  Suomalainen A, Nunnari J. Mitochondria at the crossroads of health and disease. Cell. 2024;187(11):2601-2627. doi:10.1016/j.cell.2024.04.037

24.  The Mitochondrial Medicine Society, Parikh S, Saneto R, et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol. 2009;11(6):414-430. doi:10.1007/s11940-009-0046-0

25.  Vernon H. Management of Mitochondrial Disease: The Role of Supplements and Emergency Protocols.

26.  Wen H, Deng H, Li B, et al. Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10(1):9. doi:10.1038/s41392-024-02044-3

27.  Zweers H, van Wegberg AMJ, Janssen MCH, Wortmann SB. Ketogenic diet for mitochondrial disease: a systematic review on efficacy and safety. Orphanet J Rare Dis. 2021;16:295. doi:10.1186/s13023-021-01927-w